

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 9.95900346 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 9.37863950 |
| 3 | triglyceride catabolic process (GO:0019433) | 8.26354758 |
| 4 | acylglycerol catabolic process (GO:0046464) | 7.42120186 |
| 5 | neutral lipid catabolic process (GO:0046461) | 7.42120186 |
| 6 | biotin metabolic process (GO:0006768) | 7.38362579 |
| 7 | valine metabolic process (GO:0006573) | 7.33288080 |
| 8 | * brown fat cell differentiation (GO:0050873) | 7.10476473 |
| 9 | fatty acid transmembrane transport (GO:1902001) | 6.50996667 |
| 10 | triglyceride biosynthetic process (GO:0019432) | 6.37557484 |
| 11 | * white fat cell differentiation (GO:0050872) | 6.35643691 |
| 12 | carnitine shuttle (GO:0006853) | 6.23190699 |
| 13 | lipid particle organization (GO:0034389) | 6.22770606 |
| 14 | acylglycerol biosynthetic process (GO:0046463) | 6.11860384 |
| 15 | neutral lipid biosynthetic process (GO:0046460) | 6.11860384 |
| 16 | positive regulation of fatty acid oxidation (GO:0046321) | 5.87654368 |
| 17 | fatty acid beta-oxidation (GO:0006635) | 5.84185647 |
| 18 | regulation of cholesterol storage (GO:0010885) | 5.76737958 |
| 19 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.60924910 |
| 20 | glycerolipid catabolic process (GO:0046503) | 5.57270670 |
| 21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.56405896 |
| 22 | thioester biosynthetic process (GO:0035384) | 5.49688315 |
| 23 | acyl-CoA biosynthetic process (GO:0071616) | 5.49688315 |
| 24 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.49541527 |
| 25 | lipid storage (GO:0019915) | 5.40739765 |
| 26 | branched-chain amino acid catabolic process (GO:0009083) | 5.34317615 |
| 27 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.30018008 |
| 28 | branched-chain amino acid metabolic process (GO:0009081) | 5.25630977 |
| 29 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.18909097 |
| 30 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.18637976 |
| 31 | carnitine transmembrane transport (GO:1902603) | 5.16007935 |
| 32 | fatty acid oxidation (GO:0019395) | 5.08469297 |
| 33 | regulation of fatty acid oxidation (GO:0046320) | 5.08076493 |
| 34 | lipid oxidation (GO:0034440) | 4.98894999 |
| 35 | fatty acid catabolic process (GO:0009062) | 4.96582408 |
| 36 | amino-acid betaine transport (GO:0015838) | 4.76637869 |
| 37 | carnitine transport (GO:0015879) | 4.76637869 |
| 38 | coenzyme A biosynthetic process (GO:0015937) | 4.71913263 |
| 39 | triglyceride metabolic process (GO:0006641) | 4.71113532 |
| 40 | tricarboxylic acid cycle (GO:0006099) | 4.54045647 |
| 41 | acetyl-CoA metabolic process (GO:0006084) | 4.52475093 |
| 42 | acylglycerol metabolic process (GO:0006639) | 4.45644383 |
| 43 | NADH metabolic process (GO:0006734) | 4.45373025 |
| 44 | neutral lipid metabolic process (GO:0006638) | 4.39375592 |
| 45 | cellular response to lithium ion (GO:0071285) | 4.30557075 |
| 46 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.28623733 |
| 47 | negative regulation of lipid storage (GO:0010888) | 4.20923333 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 4.18188245 |
| 49 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.17701086 |
| 50 | positive regulation of fatty acid metabolic process (GO:0045923) | 4.15071233 |
| 51 | positive regulation of lipid storage (GO:0010884) | 4.14809952 |
| 52 | positive regulation of lipid catabolic process (GO:0050996) | 4.08950828 |
| 53 | alpha-linolenic acid metabolic process (GO:0036109) | 4.08757406 |
| 54 | NADPH regeneration (GO:0006740) | 4.07900562 |
| 55 | pentose-phosphate shunt (GO:0006098) | 4.06968852 |
| 56 | negative regulation of protein autophosphorylation (GO:0031953) | 4.02722786 |
| 57 | regulation of triglyceride catabolic process (GO:0010896) | 3.99984271 |
| 58 | response to dietary excess (GO:0002021) | 3.96973754 |
| 59 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.93507025 |
| 60 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.91302989 |
| 61 | protein heterotrimerization (GO:0070208) | 3.90837837 |
| 62 | fatty acid homeostasis (GO:0055089) | 3.87715179 |
| 63 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.82498686 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 3.82161548 |
| 65 | negative regulation of granulocyte differentiation (GO:0030853) | 3.81189483 |
| 66 | glycerol metabolic process (GO:0006071) | 3.78384964 |
| 67 | intracellular lipid transport (GO:0032365) | 3.78119233 |
| 68 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.76451247 |
| 69 | monocarboxylic acid catabolic process (GO:0072329) | 3.73330641 |
| 70 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.69688981 |
| 71 | coenzyme A metabolic process (GO:0015936) | 3.69401927 |
| 72 | regulation of lipid storage (GO:0010883) | 3.64265444 |
| 73 | succinate metabolic process (GO:0006105) | 3.63241838 |
| 74 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.63078758 |
| 75 | long-chain fatty acid transport (GO:0015909) | 3.59957880 |
| 76 | regulation of triglyceride metabolic process (GO:0090207) | 3.59069927 |
| 77 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.59037907 |
| 78 | positive regulation of glomerulus development (GO:0090193) | 3.56967820 |
| 79 | quaternary ammonium group transport (GO:0015697) | 3.56364814 |
| 80 | thioester metabolic process (GO:0035383) | 3.52755151 |
| 81 | acyl-CoA metabolic process (GO:0006637) | 3.52755151 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 3.50144299 |
| 83 | positive regulation of glucose import (GO:0046326) | 3.49189678 |
| 84 | cellular lipid catabolic process (GO:0044242) | 3.48793832 |
| 85 | regulation of coenzyme metabolic process (GO:0051196) | 3.48478827 |
| 86 | regulation of cofactor metabolic process (GO:0051193) | 3.48478827 |
| 87 | negative regulation of phagocytosis (GO:0050765) | 3.46559326 |
| 88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.46015392 |
| 89 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.44838399 |
| 90 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.41021244 |
| 91 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.39293821 |
| 92 | alditol metabolic process (GO:0019400) | 3.38056985 |
| 93 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.37303383 |
| 94 | oxaloacetate metabolic process (GO:0006107) | 3.34858523 |
| 95 | phosphatidic acid metabolic process (GO:0046473) | 3.34049544 |
| 96 | phosphatidic acid biosynthetic process (GO:0006654) | 3.34049544 |
| 97 | cellular response to epinephrine stimulus (GO:0071872) | 3.33801665 |
| 98 | complement activation, alternative pathway (GO:0006957) | 3.30709627 |
| 99 | ovulation from ovarian follicle (GO:0001542) | 3.29008419 |
| 100 | negative regulation of macrophage differentiation (GO:0045650) | 3.28714882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 7.21356487 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.32924548 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.04337989 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.90508730 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.86728637 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61853448 |
| 7 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.55402342 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.51110856 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14005475 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10510868 |
| 11 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.05807522 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 16.2420175 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97218286 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90421740 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89141818 |
| 16 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.87572503 |
| 17 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.76898993 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64347503 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64132042 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60165321 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45508683 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.44406894 |
| 23 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.44280439 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40163787 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31388017 |
| 26 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.28584191 |
| 27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.28584191 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20548100 |
| 29 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13488343 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08019358 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05192342 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04665214 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04146751 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00048103 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95410990 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94677728 |
| 37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93652758 |
| 38 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93282825 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92799482 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91789873 |
| 41 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91696525 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90829971 |
| 43 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.89927642 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89406341 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.89276587 |
| 46 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89164699 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87318716 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86325388 |
| 49 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86240231 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80970162 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80801957 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76427586 |
| 53 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75365413 |
| 54 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75010195 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74246806 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73804924 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73207987 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.70564340 |
| 59 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69080058 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.68778289 |
| 61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.68521324 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.67418400 |
| 63 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67382920 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.66230160 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65155497 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64919247 |
| 67 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.63677103 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63030437 |
| 69 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.62217418 |
| 70 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.62182654 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60918965 |
| 72 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.60883337 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60361085 |
| 74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60167009 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.60143558 |
| 76 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.59673150 |
| 77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.59673024 |
| 78 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.59340318 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58923714 |
| 80 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.58916820 |
| 81 | P300_27268052_Chip-Seq_Bcells_Human | 0.57793764 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.57470328 |
| 83 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.56974259 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.56966427 |
| 85 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.56258129 |
| 86 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.55892646 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 0.55152541 |
| 88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.54500389 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.53607078 |
| 90 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.53182782 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.53110418 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.52076654 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51499881 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.51203544 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.51203544 |
| 96 | KDM2B_26808549_Chip-Seq_K562_Human | 0.51129870 |
| 97 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.49254157 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.48513970 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.48324943 |
| 100 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.48134357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.63293052 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.97421127 |
| 3 | MP0004185_abnormal_adipocyte_glucose | 5.53849292 |
| 4 | MP0004130_abnormal_muscle_cell | 5.38758862 |
| 5 | MP0005375_adipose_tissue_phenotype | 4.25585389 |
| 6 | MP0002971_abnormal_brown_adipose | 3.63225265 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 3.62749371 |
| 8 | MP0000013_abnormal_adipose_tissue | 3.20781749 |
| 9 | MP0000003_abnormal_adipose_tissue | 2.89404018 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.88937963 |
| 11 | MP0009115_abnormal_fat_cell | 2.82092447 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.80896845 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.68606839 |
| 14 | MP0005334_abnormal_fat_pad | 2.56873686 |
| 15 | MP0005275_abnormal_skin_tensile | 2.43466435 |
| 16 | MP0002970_abnormal_white_adipose | 2.39516460 |
| 17 | MP0005535_abnormal_body_temperature | 2.17250531 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.10621929 |
| 19 | MP0001661_extended_life_span | 2.10089422 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.91805145 |
| 21 | MP0003959_abnormal_lean_body | 1.80524206 |
| 22 | MP0003724_increased_susceptibility_to | 1.66861088 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.64807526 |
| 24 | MP0001881_abnormal_mammary_gland | 1.61029201 |
| 25 | MP0005448_abnormal_energy_balance | 1.60749609 |
| 26 | MP0003186_abnormal_redox_activity | 1.59010366 |
| 27 | MP0003646_muscle_fatigue | 1.53325107 |
| 28 | MP0005452_abnormal_adipose_tissue | 1.50403845 |
| 29 | MP0004272_abnormal_basement_membrane | 1.47999341 |
| 30 | MP0005365_abnormal_bile_salt | 1.40573265 |
| 31 | MP0000609_abnormal_liver_physiology | 1.38703472 |
| 32 | MP0002078_abnormal_glucose_homeostasis | 1.36828963 |
| 33 | MP0006138_congestive_heart_failure | 1.28986897 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.26925632 |
| 35 | MP0003828_pulmonary_edema | 1.26880963 |
| 36 | MP0002796_impaired_skin_barrier | 1.25861496 |
| 37 | MP0003690_abnormal_glial_cell | 1.22524268 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.16883578 |
| 39 | MP0002060_abnormal_skin_morphology | 1.03906758 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03847668 |
| 41 | MP0000750_abnormal_muscle_regeneration | 1.01131862 |
| 42 | MP0000343_altered_response_to | 1.00667502 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 0.93409818 |
| 44 | MP0001501_abnormal_sleep_pattern | 0.92662952 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 0.92194437 |
| 46 | MP0005385_cardiovascular_system_phenoty | 0.92194437 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92095535 |
| 48 | MP0003011_delayed_dark_adaptation | 0.91656088 |
| 49 | MP0002166_altered_tumor_susceptibility | 0.91026533 |
| 50 | MP0001727_abnormal_embryo_implantation | 0.88882382 |
| 51 | MP0003045_fibrosis | 0.88636107 |
| 52 | MP0002909_abnormal_adrenal_gland | 0.86336934 |
| 53 | MP0005620_abnormal_muscle_contractility | 0.85667103 |
| 54 | MP0004087_abnormal_muscle_fiber | 0.85350588 |
| 55 | MP0008961_abnormal_basal_metabolism | 0.84898370 |
| 56 | MP0002254_reproductive_system_inflammat | 0.84001821 |
| 57 | MP0003566_abnormal_cell_adhesion | 0.83139482 |
| 58 | MP0005332_abnormal_amino_acid | 0.82288637 |
| 59 | MP0005164_abnormal_response_to | 0.80714827 |
| 60 | MP0001764_abnormal_homeostasis | 0.79611422 |
| 61 | MP0003948_abnormal_gas_homeostasis | 0.78680805 |
| 62 | MP0003953_abnormal_hormone_level | 0.78434631 |
| 63 | MP0002332_abnormal_exercise_endurance | 0.78415557 |
| 64 | MP0000759_abnormal_skeletal_muscle | 0.78391338 |
| 65 | MP0000751_myopathy | 0.76178836 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 0.75700204 |
| 67 | MP0002139_abnormal_hepatobiliary_system | 0.73161493 |
| 68 | MP0005330_cardiomyopathy | 0.70683750 |
| 69 | MP0004147_increased_porphyrin_level | 0.69902245 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 0.67518868 |
| 71 | MP0002006_tumorigenesis | 0.66317106 |
| 72 | MP0001756_abnormal_urination | 0.66100863 |
| 73 | MP0009643_abnormal_urine_homeostasis | 0.64530736 |
| 74 | MP0002168_other_aberrant_phenotype | 0.64416734 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 0.63879155 |
| 76 | MP0003950_abnormal_plasma_membrane | 0.60401701 |
| 77 | MP0002972_abnormal_cardiac_muscle | 0.60273828 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.59168134 |
| 79 | MP0005410_abnormal_fertilization | 0.56136852 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.52784462 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.52031033 |
| 82 | MP0010630_abnormal_cardiac_muscle | 0.48958660 |
| 83 | MP0001853_heart_inflammation | 0.48457842 |
| 84 | MP0002295_abnormal_pulmonary_circulatio | 0.48353658 |
| 85 | MP0001177_atelectasis | 0.47956587 |
| 86 | MP0009672_abnormal_birth_weight | 0.47891077 |
| 87 | MP0005647_abnormal_sex_gland | 0.47845745 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.47250347 |
| 89 | MP0002009_preneoplasia | 0.47057582 |
| 90 | MP0009763_increased_sensitivity_to | 0.46757257 |
| 91 | MP0000249_abnormal_blood_vessel | 0.46604778 |
| 92 | MP0005501_abnormal_skin_physiology | 0.46235246 |
| 93 | MP0002108_abnormal_muscle_morphology | 0.45503174 |
| 94 | MP0002133_abnormal_respiratory_system | 0.44678166 |
| 95 | MP0005388_respiratory_system_phenotype | 0.44678166 |
| 96 | MP0005058_abnormal_lysosome_morphology | 0.43352576 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.43210019 |
| 98 | MP0003448_altered_tumor_morphology | 0.40576609 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.40278270 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.39878955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 8.24532740 |
| 2 | Acanthosis nigricans (HP:0000956) | 6.98043470 |
| 3 | Hyperglycinuria (HP:0003108) | 6.59305609 |
| 4 | Hypertriglyceridemia (HP:0002155) | 6.30014858 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 5.35790762 |
| 6 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.35790762 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.00027017 |
| 8 | Myoglobinuria (HP:0002913) | 4.88612568 |
| 9 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.68846261 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.45886013 |
| 11 | Increased muscle lipid content (HP:0009058) | 4.37094957 |
| 12 | Difficulty running (HP:0009046) | 4.21406341 |
| 13 | Complement deficiency (HP:0004431) | 4.04980260 |
| 14 | Long foot (HP:0001833) | 4.02579976 |
| 15 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.02417884 |
| 16 | Rhabdomyolysis (HP:0003201) | 3.96778199 |
| 17 | Abnormality of proline metabolism (HP:0010907) | 3.80944615 |
| 18 | Hydroxyprolinuria (HP:0003080) | 3.80944615 |
| 19 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.78632504 |
| 20 | Dicarboxylic aciduria (HP:0003215) | 3.78632504 |
| 21 | Ketoacidosis (HP:0001993) | 3.73754788 |
| 22 | Growth hormone excess (HP:0000845) | 3.66689314 |
| 23 | Insulin resistance (HP:0000855) | 3.59424288 |
| 24 | Nausea (HP:0002018) | 3.57944679 |
| 25 | Ketosis (HP:0001946) | 3.57659857 |
| 26 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.46834476 |
| 27 | Bone cyst (HP:0012062) | 3.43041331 |
| 28 | Hyperglycinemia (HP:0002154) | 3.30235348 |
| 29 | Multiple enchondromatosis (HP:0005701) | 3.28293462 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.24753470 |
| 31 | Hyperammonemia (HP:0001987) | 3.12695407 |
| 32 | Subcapsular cataract (HP:0000523) | 2.96406112 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 2.95529229 |
| 34 | Epidermoid cyst (HP:0200040) | 2.93072509 |
| 35 | Abnormality of complement system (HP:0005339) | 2.89499960 |
| 36 | Increased connective tissue (HP:0009025) | 2.88952588 |
| 37 | Hepatic necrosis (HP:0002605) | 2.88377652 |
| 38 | Large hands (HP:0001176) | 2.85855249 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.83889178 |
| 40 | Hyperthyroidism (HP:0000836) | 2.72378558 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.71838674 |
| 42 | Pancreatitis (HP:0001733) | 2.68050714 |
| 43 | Hyperpituitarism (HP:0010514) | 2.67631951 |
| 44 | Myocardial infarction (HP:0001658) | 2.59918555 |
| 45 | Muscle stiffness (HP:0003552) | 2.55284114 |
| 46 | Abnormal cartilage morphology (HP:0002763) | 2.51785721 |
| 47 | Toxemia of pregnancy (HP:0100603) | 2.50503238 |
| 48 | Prenatal maternal abnormality (HP:0002686) | 2.49906982 |
| 49 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46221699 |
| 50 | Abnormality of alanine metabolism (HP:0010916) | 2.46221699 |
| 51 | Hyperalaninemia (HP:0003348) | 2.46221699 |
| 52 | Thyroid-stimulating hormone excess (HP:0002925) | 2.41617488 |
| 53 | Ankle contracture (HP:0006466) | 2.34006761 |
| 54 | Abnormality of glycolysis (HP:0004366) | 2.32954374 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.32954374 |
| 56 | Facial diplegia (HP:0001349) | 2.29214525 |
| 57 | Brushfield spots (HP:0001088) | 2.26207486 |
| 58 | Decreased subcutaneous fat (HP:0001002) | 2.25133232 |
| 59 | Tetraparesis (HP:0002273) | 2.22375384 |
| 60 | Abnormal hemoglobin (HP:0011902) | 2.21891995 |
| 61 | Spinal rigidity (HP:0003306) | 2.20924721 |
| 62 | Hyperlipoproteinemia (HP:0010980) | 2.20178441 |
| 63 | Renal cortical cysts (HP:0000803) | 2.20161675 |
| 64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20065214 |
| 65 | Accelerated skeletal maturation (HP:0005616) | 2.17908181 |
| 66 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16368365 |
| 67 | Hyperglycemia (HP:0003074) | 2.14977154 |
| 68 | Cerebral aneurysm (HP:0004944) | 2.13563417 |
| 69 | Limb hypertonia (HP:0002509) | 2.13280873 |
| 70 | Polygenic inheritance (HP:0010982) | 2.13238930 |
| 71 | Broad metatarsal (HP:0001783) | 2.12599872 |
| 72 | Lethargy (HP:0001254) | 2.11997207 |
| 73 | Lipoatrophy (HP:0100578) | 2.11742563 |
| 74 | Hypercortisolism (HP:0001578) | 2.08928897 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.07918021 |
| 76 | Type 1 muscle fiber predominance (HP:0003803) | 2.06192752 |
| 77 | Prominent supraorbital ridges (HP:0000336) | 2.04546720 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.04437227 |
| 79 | Skin nodule (HP:0200036) | 2.03915219 |
| 80 | Xanthomatosis (HP:0000991) | 2.03747494 |
| 81 | Conjunctival hamartoma (HP:0100780) | 2.02859837 |
| 82 | Turricephaly (HP:0000262) | 2.00815823 |
| 83 | Cerebral edema (HP:0002181) | 1.97208086 |
| 84 | Abnormality of serum amino acid levels (HP:0003112) | 1.96116771 |
| 85 | Exercise-induced myalgia (HP:0003738) | 1.96086784 |
| 86 | Hypercholesterolemia (HP:0003124) | 1.92986636 |
| 87 | Hyporeflexia of lower limbs (HP:0002600) | 1.92837039 |
| 88 | Vomiting (HP:0002013) | 1.91717680 |
| 89 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.90175785 |
| 90 | Neonatal hypoglycemia (HP:0001998) | 1.90034407 |
| 91 | Tachypnea (HP:0002789) | 1.89611105 |
| 92 | Polyphagia (HP:0002591) | 1.88098233 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 1.86585869 |
| 94 | Polar cataract (HP:0010696) | 1.85488602 |
| 95 | Proximal tubulopathy (HP:0000114) | 1.85484088 |
| 96 | Clitoromegaly (HP:0000057) | 1.85358255 |
| 97 | Gonadotropin excess (HP:0000837) | 1.84216144 |
| 98 | Muscle fiber splitting (HP:0003555) | 1.83626666 |
| 99 | Acute encephalopathy (HP:0006846) | 1.81308066 |
| 100 | Abnormal eating behavior (HP:0100738) | 1.78867637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 6.35589168 |
| 2 | TRIB3 | 5.27849232 |
| 3 | BCKDK | 5.01283985 |
| 4 | CAMK1G | 4.60472305 |
| 5 | PDK3 | 4.39610705 |
| 6 | PDK4 | 4.39610705 |
| 7 | SIK1 | 4.06095516 |
| 8 | PDK2 | 2.68744369 |
| 9 | ERN1 | 2.18457783 |
| 10 | RIPK1 | 2.14975274 |
| 11 | LMTK2 | 2.08604180 |
| 12 | PRKAA2 | 1.90445135 |
| 13 | MST1R | 1.88187215 |
| 14 | CDK9 | 1.84415834 |
| 15 | PRKD3 | 1.47012674 |
| 16 | EPHB2 | 1.39882304 |
| 17 | INSRR | 1.36089942 |
| 18 | CDK6 | 1.31067489 |
| 19 | PDGFRA | 1.24369661 |
| 20 | MAP3K6 | 1.23547968 |
| 21 | MAP2K1 | 1.22266189 |
| 22 | DDR2 | 1.17623122 |
| 23 | FGFR3 | 1.13535210 |
| 24 | FGFR2 | 1.08301409 |
| 25 | FRK | 1.05894042 |
| 26 | PKN2 | 1.03869770 |
| 27 | TIE1 | 0.99674426 |
| 28 | ICK | 0.99616358 |
| 29 | PRKAA1 | 0.97627609 |
| 30 | PDPK1 | 0.93199013 |
| 31 | TGFBR2 | 0.90801164 |
| 32 | PIK3CA | 0.87390501 |
| 33 | LATS1 | 0.86175671 |
| 34 | IRAK3 | 0.86140584 |
| 35 | PHKG1 | 0.85903693 |
| 36 | PHKG2 | 0.85903693 |
| 37 | PINK1 | 0.77734784 |
| 38 | LATS2 | 0.77458393 |
| 39 | PDK1 | 0.76782104 |
| 40 | JAK1 | 0.76625732 |
| 41 | MET | 0.75569743 |
| 42 | FGFR4 | 0.65488578 |
| 43 | GSK3A | 0.64511665 |
| 44 | ILK | 0.64122925 |
| 45 | FER | 0.63883043 |
| 46 | JAK2 | 0.63360292 |
| 47 | BMX | 0.63117753 |
| 48 | MTOR | 0.60173215 |
| 49 | PRKACG | 0.59716861 |
| 50 | PTK2B | 0.58032334 |
| 51 | TTN | 0.56981601 |
| 52 | PRKCH | 0.56337344 |
| 53 | MYLK | 0.55736021 |
| 54 | MAPK11 | 0.55216542 |
| 55 | CAMK1 | 0.54719595 |
| 56 | TNK2 | 0.54641153 |
| 57 | PDGFRB | 0.53852477 |
| 58 | NEK9 | 0.53106797 |
| 59 | CDK4 | 0.52370291 |
| 60 | IGF1R | 0.51875619 |
| 61 | RET | 0.48451702 |
| 62 | FLT3 | 0.48280507 |
| 63 | PRKD1 | 0.48194159 |
| 64 | PAK2 | 0.43161819 |
| 65 | PRKD2 | 0.42862265 |
| 66 | MAP2K3 | 0.42844825 |
| 67 | INSR | 0.42320401 |
| 68 | IRAK1 | 0.40115582 |
| 69 | CAMKK2 | 0.38119575 |
| 70 | EIF2AK2 | 0.37685175 |
| 71 | FGFR1 | 0.36261691 |
| 72 | RPS6KB1 | 0.35859492 |
| 73 | PRKG2 | 0.35517837 |
| 74 | TYRO3 | 0.35122945 |
| 75 | STK3 | 0.34949313 |
| 76 | JAK3 | 0.34211561 |
| 77 | MAP3K3 | 0.33119077 |
| 78 | STK38 | 0.28198843 |
| 79 | CSK | 0.27885945 |
| 80 | MAPK12 | 0.27011048 |
| 81 | SRC | 0.26283569 |
| 82 | TESK1 | 0.26243302 |
| 83 | IRAK2 | 0.26041624 |
| 84 | ABL2 | 0.25482440 |
| 85 | DAPK2 | 0.25299830 |
| 86 | LRRK2 | 0.22505563 |
| 87 | MAPKAPK3 | 0.21053766 |
| 88 | MARK2 | 0.20289816 |
| 89 | EPHB1 | 0.20289500 |
| 90 | MAP2K4 | 0.18489036 |
| 91 | PRKCZ | 0.18275408 |
| 92 | EEF2K | 0.18205442 |
| 93 | AKT1 | 0.18004250 |
| 94 | STK38L | 0.17774685 |
| 95 | MAPK4 | 0.17535898 |
| 96 | TRPM7 | 0.16670573 |
| 97 | KSR2 | 0.16375879 |
| 98 | STK11 | 0.15474542 |
| 99 | CSF1R | 0.14224799 |
| 100 | ABL1 | 0.13702981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 5.14022976 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.96858718 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.42710939 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.24696878 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 4.02293151 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.80028258 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.73330464 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.36751872 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.06435873 |
| 10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.80667075 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.64013745 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18774862 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.12010252 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.03906226 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.03116257 |
| 16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.91569623 |
| 17 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.76472394 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.59985955 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.58270785 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56783289 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52920934 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46901391 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19591349 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08563727 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.08112250 |
| 26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05072878 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03757653 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03277788 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99852665 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98732800 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92252410 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87804844 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87540608 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87342529 |
| 35 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83314413 |
| 36 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82844422 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82332174 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82163603 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73108634 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71241328 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 0.64021589 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55645754 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53921809 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51602026 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50129129 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49777985 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46656515 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46126191 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45873603 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43459158 |
| 51 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43384825 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.42245873 |
| 53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40960950 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.39378633 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38879331 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35308294 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33290922 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32228951 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.32042467 |
| 60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31594453 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31024341 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.30500758 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29816653 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29003791 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.28849459 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28802740 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28229440 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25465134 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24176586 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23522929 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23430632 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23102440 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22769907 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19973523 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19844287 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.19497608 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19015626 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.17009500 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.16684485 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.16465833 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13366213 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10743257 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.07507145 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.05864077 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03743835 |
| 86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.03292680 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.02243876 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00804780 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.00336835 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00117767 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.00045552 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0522448 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | -0.0411798 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | -0.0405474 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0333249 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.0293364 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0233911 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0224385 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | -0.0194490 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0043867 |

